| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.005 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |